Kinara

Articles

View all

August 14, 2025

9 Minute Read

It’s 2025. Women’s Health Still Isn’t a Priority.

Meg Rivera

August 8, 2025

11 Minute Read

Leading with Authenticity in the Rare Disease Space: A Q&A with Ascendis’ Jay Donovan Wu

Chase Feiger

August 1, 2025

15 Minute Read

40 Years on the HIV front lines with ViiV’s ‘Good Troublemaker’ Kimberly Smith

Larry Dobrow

July 17, 2025

10 Minute Read

Trust, Truth and Triage: Life Sciences in the Age of AI Misinformation

Larry Dobrow

July 10, 2025

9 Minute Read

Lead-Gen Isn’t Sexy. But If You’re Not Using It to Drive Demand and Improve Outcomes, You’re Doing It Wrong.

Nikki Murphy

July 2, 2025

7 Minute Read

The Future of Cancer Treatment: A Q&A with Akari Therapeutics CEO Abizer Gaslightwala

Chase Feiger

Five Questions

View all

August 13, 2025

Alison Tapia, Digital Innovation and Omnichannel Expert

Alison Tapia

August 12, 2025

Coming Soon: Derrick Gastineau, Head of Marketing, Currax Pharmaceuticals

Derrick Gastineau

August 11, 2025

Coming Soon: Will McMahon, Director, Omnichannel Strategy, AstraZeneca

Will McMahon

Podcast

View all

August 5, 2025

Trailer | The Mechanics of Pharma M&A with Devang Bhuva, SVP, Corporate Development at Gilead Sciences

Devang Bhuva

July 21, 2025

Trailer | Science and Service: Ascendis’ Jay Donovan Wu on Leading with Authenticity in the Rare Disease Space

Jay Donovan Wu

June 4, 2025

Trailer | Breaking Down Barriers: Akari’s CEO on the Future of Cancer Treatment

Abizer Gaslightwala

April 16, 2025

Trailer | Transforming Maternal Mental Health: Sage Therapeutics’ CEO on the Future of Postpartum Depression Treatment

Barry Greene

January 29, 2025

Trailer | Building a First-Tier Pharma Culture: Bruce Cozadd CEO of Jazz Pharmaceuticals

Bruce Cozadd

December 5, 2024

Trailer | From Doctor to Drug Developer: NewAmsterdam Pharma’s CEO on Transforming Patient Care

Dr. Michael Davidson

What is Kinara?

Revolutionizing Diagnostics:

Exact Sciences CEO on What’s Next

Advancing Neurohealth:
Alkermes CEO on Innovation
and Progress

Building a First-Tier Pharma Culture:
Bruce Cozadd CEO
of Jazz Pharmaceuticals

Articles

It’s 2025. Women’s Health Still Isn’t a Priority.

Leading with Authenticity in the Rare Disease Space: A Q&A with Ascendis’ Jay Donovan Wu

40 Years on the HIV front lines with ViiV’s ‘Good Troublemaker’ Kimberly Smith

Trust, Truth and Triage: Life Sciences in the Age of AI Misinformation

Lead-Gen Isn’t Sexy. But If You’re Not Using It to Drive Demand and Improve Outcomes, You’re Doing It Wrong.

The Future of Cancer Treatment: A Q&A with Akari Therapeutics CEO Abizer Gaslightwala

Five Questions

Alison Tapia, Digital Innovation and Omnichannel Expert

Coming Soon: Derrick Gastineau, Head of Marketing, Currax Pharmaceuticals

Coming Soon: Will McMahon, Director, Omnichannel Strategy, AstraZeneca

Podcast

Trailer | The Mechanics of Pharma M&A with Devang Bhuva, SVP, Corporate Development at Gilead Sciences

Trailer | Science and Service: Ascendis’ Jay Donovan Wu on Leading with Authenticity in the Rare Disease Space

Trailer | Breaking Down Barriers: Akari’s CEO on the Future of Cancer Treatment

Trailer | Transforming Maternal Mental Health: Sage Therapeutics’ CEO on the Future of Postpartum Depression Treatment

Trailer | Building a First-Tier Pharma Culture: Bruce Cozadd CEO of Jazz Pharmaceuticals

Trailer | From Doctor to Drug Developer: NewAmsterdam Pharma’s CEO on Transforming Patient Care

Kinara

Social

Sign up to join insightful conversations with key life science executives in our monthly newsletter.